Latest On Ascendis Pharma A/S (ASND):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-08 18:47 EST | News | Ascendis Pharma added to Wedbush's best ideas list | N/A |  |
| 2023-05-02 17:38 EST | News | Ascendis Pharma Q1 Earnings: Skytrofa Soars, PTH Hurdles Yet To Clear | N/A | |
| 2023-05-01 17:06 EST | News | Ascendis' TransCon gets FDA rejection but company hopeful as no new trials requested | N/A | |
| 2023-04-28 02:05 EST | News | Ascendis Pharma A/S (ASND) Q1 2023 Earnings Call Transcript | N/A | |
| 2023-04-27 01:02 EST | News | Ascendis Pharma Q1 2023 Earnings Preview | N/A | |
| 2023-04-20 16:46 EST | News | Ascendis Pharma: A Promising Diversification Play | N/A | |
| 2023-04-17 01:29 EST | News | Ascendis Pharma: Recent FDA Setbacks Present A Buying Opportunity | N/A | |
| 2023-04-06 23:12 EST | News | Ascendis Pharma: Is Dip On TransCon Application A Buy Opportunity? | N/A | |
| 2023-04-03 14:24 EST | News | Ascendis stock slumps ~35% after FDA finds 'deficiencies' in TransCon application | N/A | |
| 2023-04-03 14:24 EST | News | Ascendis downgraded at Credit Suisse on deficiencies in drug application | N/A | |
| 2023-02-17 11:10 EST | News | Ascendis Pharma A/S (ASND) Q4 2022 Earnings Call Transcript | N/A | |
| 2023-02-16 22:05 EST | News | Ascendis Pharma GAAP EPS of -€10.40, revenue of €51.17M | N/A | |
| 2023-02-15 19:21 EST | News | Ascendis Pharma FY 2022 Earnings Preview | N/A | |
| 2023-01-27 16:41 EST | News | Ascendis: Neutral On Skytrofa's Market Launch, Initiating With A Neutral Rating | N/A | |
| 2023-01-19 02:12 EST | News | Ascendis Pharma: Group's Best Nearby Capital Gain Price-Position Stock | N/A | |
| 2022-11-17 14:37 EST | News | Ascendis, Visen' once-weekly growth hormone drug beats daily hGH in Chinese patients in trial | N/A | |
| 2022-11-14 19:34 EST | News | Ascendis falls on Phase 2 data for achondroplasia candidate | N/A | |
| 2022-11-05 05:43 EST | News | Ascendis Pharma A/S (ASND) Q3 2022 Earnings Call Transcript | N/A | |
| 2022-11-04 12:46 EST | News | Ascendis Pharma: Translating Valuable IP Into A Profitable Business | N/A | |
| 2022-11-03 02:59 EST | News | Ascendis Pharma GAAP EPS of -€3.03, revenue of €15.29M | N/A | |
| 2022-11-01 19:43 EST | News | Ascendis Pharma Q3 2022 Earnings Preview | N/A | |
| 2022-11-01 03:36 EST | News | Ascendis parathyroid hormone therapy goes under FDA priority review | N/A | |
| 2022-09-16 02:59 EST | News | Ascendis Pharma: TransCon CNP Data Coming Q4 | N/A | |
| 2022-08-31 23:18 EST | News | Ascendis Pharma seeks FDA nod for its parathyroid hormone restorer TransCon PTH | N/A | |
| 2022-08-11 20:08 EST | News | Ascendis Pharma Q2 results beat buoyed by strong sales of growth hormone drug Skytrofa | N/A | |
| 2022-08-11 03:38 EST | News | Ascendis Pharma GAAP EPS of -€1.46 beats by €0.69, revenue of €6.16B beats by $6.15B | N/A | |
| 2022-08-11 03:37 EST | News | Ascendis Pharma A/S (ASND) CEO Jan Mikkelsen on Q2 2022 Results - Earnings Call Transcript | N/A | |
| 2022-08-10 09:43 EST | News | Ascendis Pharma Q2 2022 Earnings Preview | N/A | |
| 2022-08-04 05:34 EST | News | Ascendis Pharma: Institutional Buying Values Dutch Biotech Best-Now Cap-Gain Prospect | N/A | |
| 2022-05-23 09:02 EST | News | Ascendis, Visen' TransCon hGH meets main goal in growth hormone deficiency China trial in children | N/A | |
| 2022-05-13 04:45 EST | News | Ascendis Pharma slides after Street analysts cut price target over SKYTROFA revenue miss | N/A | |
| 2022-05-12 09:00 EST | News | Ascendis Pharma GAAP EPS of -€2.21 misses by €0.05, revenue of €6.83M beats by €1.98M | N/A | |
| 2022-05-12 09:00 EST | News | Ascendis Pharma A/S (ASND) CEO Jan Mikkelsen on Q1 2022 Results - Earnings Call Transcript | N/A | |
| 2022-05-10 19:27 EST | News | Ascendis Pharma Q1 2022 Earnings Preview | N/A | |
| 2022-05-09 22:24 EST | News | Ascendis Pharma: Biotech Bear Provides Attractive Entry Point | N/A | |
| 2022-04-29 17:39 EST | News | Ascendis: Institutional Buying Activity Now Seen As Good Value By Market-Makers | N/A | |
| 2022-03-25 08:03 EST | News | Ascendis Pharma prices $500.0M convertible senior notes offering | N/A | |
| 2022-03-23 22:32 EST | News | Ascendis Pharma slides on offering of $500M convertible senior notes | N/A | |
| 2022-03-16 20:02 EST | News | Ascendis posts biggest intraday gain in six months as BofA upgrades on trial results | N/A | |
| 2022-03-14 20:55 EST | News | Ascendis Pharma TransCon PTH for hypoparathyroidism meets main goal in phase 3 trial | N/A | |
| 2022-03-03 04:55 EST | News | Ascendis Pharma GAAP EPS of $7.00 beats by €15.44, revenue of €7.77M misses by $0.13M | N/A | |
| 2022-03-03 04:55 EST | News | Ascendis Pharma stock falls 7% despite Q4 bottom line beat | N/A | |
| 2022-03-03 04:55 EST | News | Ascendis Pharma A/S' (ASND) CEO Jan Mikkelsen on Q4 2021 Results - Earnings Call Transcript | N/A | |
| 2022-03-01 18:03 EST | News | Ascendis Pharma FY Earnings Preview | N/A | |
| 2022-01-25 06:13 EST | News | Pfizer/OPKO loss on somatrogon could boost Ascendis Pharma's fortunes | N/A | |
| 2022-01-24 14:23 EST | News | Ascendis Pharma (ASND) Presents At 40th Annual J.P. Morgan Virtual Healthcare Conference | N/A | |
| 2022-01-24 14:23 EST | News | Pfizer/OPKO loss on somatragon could boost Ascendis Pharma's fortunes | N/A | |
| 2022-01-14 01:12 EST | News | Ascendis Pharma's TransCon gets EU approval for growth hormone deficiency in children | N/A | |
| 2021-12-30 05:41 EST | News | Ascendis: Danish Biotech With Thin Audience Now Seen As Good Value By Market-Makers | N/A | |
| 2021-11-19 04:06 EST | News | Phase 2 data shows durable response of Ascendis candidate for hypoparathyroidism | N/A | |
About Ascendis Pharma A/S (ASND):
Ascendis Pharma A/S, a biopharmaceutical company, develops therapeutics for unmet medical needs. The company develops TransCon growth hormone, which completed Phase III clinical trials for growth hormone deficiency. It also develops TransCon parathyroid hormone for adult hypoparathyroidism; and TransCon CNP for achondroplasia. In addition, the company develops preclinical studies in the field of oncology for potential product candidates and evaluate systemic and localized delivery systems using its TransCon technologies. The company was incorporated in 2006 and is headquartered in Hellerup, Denmark.
General
- Name Ascendis Pharma A/S
- Symbol ASND
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 482
- Fiscal Year EndDecember
- IPO Date2015-01-28
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryBiotechnology
- Web URLhttp://www.ascendispharma.com
View More
Valuation
- Price/Sales (Trailing 12 Mt.) 917.83
- Price/Book (Most Recent Quarter) 8.08
- Enterprise Value Revenue 1052.08
View More
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate -$8.67
- Next Year EPS Estimate -$7.26
- Next Quarter EPS Estimate -$2.01
- Return on Assets -25%
- Return on Equity -58%
- Earnings Per Share -$5.09
- Revenue Per Share $0
- Gross Profit 6.95 million
- Quarterly Earnings Growth -78.7%
View More
Highlights
- Market Capitalization 7.87 billion
- Analyst Target Price $194.63
- Book Value Per Share $8.43
View More
Share Statistics
- Shares Outstanding 53.75 million
- Shares Float 43.76 million
- % Held by Insiders 3%
- % Held by Institutions 101.6%
- Shares Short 2.48 million
- Shares Short Prior Month 2.21 million
- Short Ratio 11.66
- Short % of Shares Outstanding 5%
View More
Technicals
- Beta 0.79
- 52 Week High $183.98
- 52 Week Low $96.24
- 50 Day Moving Average 152.16
- 200 Day Moving Average 158.57
View More
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
View More
Ascendis Pharma A/S (ASND) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Ascendis Pharma A/S (ASND) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2021-03-10 | $535000 | -$3.15 | -$1.87 | -68.17% |
| 2020-09-30 | 2020-11-11 | $2.76 million | -$2.72 | -$1.87 | -45.17% |
| 2020-06-30 | 2020-08-27 | $1.44 million | -$2.33 | -$1.61 | -44.68% |
| 2020-03-31 | 2020-05-19 | $2.23 million | -$1.44 | -$1.41 | -2.66% |
| 2019-12-31 | 2019-12-31 | $2.51 million | -$1.89 | -$1.62 | -16.67% |
| 2019-09-30 | 2019-11-18 | $2.44 million | -$0.59 | -$1.29 | 54.34% |
| 2019-06-30 | 2019-08-28 | $3.62 million | -$1.38 | -$1.33 | -4.4% |
| 2019-03-31 | 2019-05-30 | $6.07 million | -$1.38 | -$1.14 | -20.89% |
| 2018-12-31 | 2018-12-31 | $12.06 million | -$0.86 | -$1.14 | 24.56% |
| 2018-09-30 | 2018-11-28 | $23153.51 | -$0.92 | -$1.19 | 22.87% |
| 2018-06-30 | 2018-08-29 | $20949.72 | -$0.64 | -$1.00 | 35.45% |
| 2018-03-31 | 2018-05-30 | $34444.58 | -$1.25 | -$0.88 | -41.8% |
| 2017-12-31 | 2018-03-28 | $362000 | -$1.13 | -$0.99 | -14.12% |
| 2017-09-30 | 2017-11-16 | $546000 | -$1.22 | -$0.86 | -42.4% |
| 2017-06-30 | 2017-08-18 | $533000 | -$1.11 | -$0.88 | -26.09% |
| 2017-03-31 | 2017-05-23 | $398000 | -$0.87 | -$0.76 | -15.03% |
| 2016-12-31 | 2017-03-22 | $855000 | -$0.55 | -$0.71 | 22.7% |
| 2016-09-30 | 2016-11-30 | $1.36 million | -$0.76 | -$0.64 | -19.56% |
| 2016-06-30 | 2016-08-31 | $1.21 million | -$0.59 | -$0.65 | 8.96% |
| 2016-03-31 | 2016-04-14 | $1.43 million | -$0.59 | -$0.30 | -95.13% |
| 2015-09-30 | 2015-11-12 | $2.37 million | -$0.29 | -$0.56 | 48.21% |
| 2015-06-30 | 2015-08-24 | $2.25 million | -$0.63 | -$0.43 | -46.51% |
| 2015-03-31 | 2015-05-18 | $2.24 million | $0.07 | -$0.39 | 117.95% |
| 2014-12-31 | 2015-01-28 | $2.83 million | -$0.65 |
Ascendis Pharma A/S (ASND) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
Ascendis Pharma A/S (ASND) Chart:
Ascendis Pharma A/S (ASND) News:
Below you will find a list of latest news for Ascendis Pharma A/S (ASND) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Ascendis Pharma A/S (ASND) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|---|---|---|---|---|---|---|---|---|
| 2025-10-17 | 75 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2025-10-17 | 80 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2025-10-17 | 85 | 103.5 | CALL | 0 | 0 | 163.3 | TRUE | 0 | 0 |
| 2025-10-17 | 90 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2025-10-17 | 95 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2025-10-17 | 100 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2025-10-17 | 105 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2025-10-17 | 110 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2025-10-17 | 115 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2025-10-17 | 120 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2025-10-17 | 125 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2025-10-17 | 130 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2025-10-17 | 135 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2025-10-17 | 140 | 0 | CALL | 0 | 0 | 79.22 | TRUE | 0 | 0 |
| 2025-10-17 | 145 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2025-10-17 | 150 | 0 | CALL | 0 | 0 | 63.27 | TRUE | 0 | 0 |
| 2025-10-17 | 155 | 42.6 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2025-10-17 | 160 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2025-10-17 | 165 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2025-10-17 | 170 | 21.5 | CALL | 0 | 6 | 31.06 | TRUE | 0 | 0 |
| 2025-10-17 | 175 | 28.5 | CALL | 0 | 2 | 44.26 | TRUE | 0 | 0 |
| 2025-10-17 | 180 | 23.8 | CALL | 0 | 3 | 45.1 | TRUE | 0 | 0 |
| 2025-10-17 | 185 | 17.5 | CALL | 0 | 201 | 46.34 | TRUE | 0 | 0 |
| 2025-10-17 | 190 | 16.61 | CALL | 0 | 10 | 43.62 | TRUE | 0 | 0 |
| 2025-10-17 | 195 | 4.9 | CALL | 0 | 19 | 41.3 | TRUE | 0 | 0 |
| 2025-10-17 | 200 | 8.3 | CALL | 53 | 1507 | 38.67 | TRUE | 0.9 | 0.12 |
| 2025-10-17 | 210 | 3.48 | CALL | 1 | 210 | 37.74 | FALSE | -0.02 | -0.01 |
| 2025-10-17 | 220 | 1.2 | CALL | 2 | 999 | 38.04 | FALSE | -0.29 | -0.19 |
| 2025-10-17 | 230 | 2.05 | CALL | 0 | 9 | 40.8 | FALSE | 0 | 0 |
| 2025-10-17 | 240 | 1.3 | CALL | 0 | 231 | 47.88 | FALSE | 0 | 0 |
| 2025-10-17 | 250 | 1.05 | CALL | 0 | 6 | 57.45 | FALSE | 0 | 0 |
| 2025-10-17 | 260 | 0.06 | CALL | 0 | 2 | 66.37 | FALSE | 0 | 0 |
| 2025-10-17 | 75 | 0 | PUT | 0 | 0 | 264.39 | FALSE | 0 | 0 |
| 2025-10-17 | 80 | 0 | PUT | 0 | 0 | 248.59 | FALSE | 0 | 0 |
| 2025-10-17 | 85 | 0 | PUT | 0 | 0 | 233.77 | FALSE | 0 | 0 |
| 2025-10-17 | 90 | 0 | PUT | 0 | 0 | 219.81 | FALSE | 0 | 0 |
| 2025-10-17 | 95 | 0 | PUT | 0 | 0 | 206.61 | FALSE | 0 | 0 |
| 2025-10-17 | 100 | 0 | PUT | 0 | 0 | 194.09 | FALSE | 0 | 0 |
| 2025-10-17 | 105 | 0 | PUT | 0 | 1 | 182.16 | FALSE | 0 | 0 |
| 2025-10-17 | 110 | 0 | PUT | 0 | 1 | 170.78 | FALSE | 0 | 0 |
| 2025-10-17 | 115 | 0 | PUT | 0 | 0 | 159.88 | FALSE | 0 | 0 |
| 2025-10-17 | 120 | 1.85 | PUT | 0 | 1 | 149.41 | FALSE | 0 | 0 |
| 2025-10-17 | 125 | 2.45 | PUT | 0 | 2 | 139.33 | FALSE | 0 | 0 |
| 2025-10-17 | 130 | 2.9 | PUT | 0 | 3 | 129.61 | FALSE | 0 | 0 |
| 2025-10-17 | 135 | 1.43 | PUT | 0 | 0 | 120.22 | FALSE | 0 | 0 |
| 2025-10-17 | 140 | 0 | PUT | 0 | 0 | 111.11 | FALSE | 0 | 0 |
| 2025-10-17 | 145 | 0.8 | PUT | 0 | 1 | 102.26 | FALSE | 0 | 0 |
| 2025-10-17 | 150 | 0 | PUT | 0 | 0 | 93.65 | FALSE | 0 | 0 |
| 2025-10-17 | 155 | 1.07 | PUT | 0 | 1 | 85.24 | FALSE | 0 | 0 |
| 2025-10-17 | 160 | 1.24 | PUT | 0 | 2 | 77.01 | FALSE | 0 | 0 |
| 2025-10-17 | 165 | 1.57 | PUT | 0 | 1 | 62.54 | FALSE | 0 | 0 |
| 2025-10-17 | 170 | 1.34 | PUT | 0 | 454 | 58.27 | FALSE | 0 | 0 |
| 2025-10-17 | 175 | 2.6 | PUT | 0 | 5 | 54.26 | FALSE | 0 | 0 |
| 2025-10-17 | 180 | 3.71 | PUT | 0 | 109 | 50.01 | FALSE | 0 | 0 |
| 2025-10-17 | 185 | 5.1 | PUT | 0 | 208 | 47.83 | FALSE | 0 | 0 |
| 2025-10-17 | 190 | 8.6 | PUT | 0 | 260 | 44.83 | FALSE | 0 | 0 |
| 2025-10-17 | 195 | 8.5 | PUT | 0 | 351 | 42.7 | FALSE | 0 | 0 |
| 2025-10-17 | 200 | 13.9 | PUT | 0 | 2 | 39.55 | FALSE | 0 | 0 |
| 2025-10-17 | 210 | 16.53 | PUT | 0 | 1 | 38.37 | TRUE | 0 | 0 |
| 2025-10-17 | 220 | 0 | PUT | 0 | 0 | 39.05 | TRUE | 0 | 0 |
| 2025-10-17 | 230 | 51 | PUT | 0 | 0 | 49.46 | TRUE | 0 | 0 |
| 2025-10-17 | 240 | 70 | PUT | 0 | 0 | 54.22 | TRUE | 0 | 0 |
| 2025-10-17 | 250 | 0 | PUT | 0 | 0 | 64.66 | TRUE | 0 | 0 |
| 2025-10-17 | 260 | 0 | PUT | 0 | 0 | 62.38 | TRUE | 0 | 0 |
| 2025-11-21 | 140 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2025-11-21 | 145 | 0 | CALL | 0 | 0 | 54.85 | TRUE | 0 | 0 |
| 2025-11-21 | 150 | 0 | CALL | 0 | 0 | 51.52 | TRUE | 0 | 0 |
| 2025-11-21 | 155 | 0 | CALL | 0 | 0 | 49.45 | TRUE | 0 | 0 |
| 2025-11-21 | 160 | 0 | CALL | 0 | 0 | 46.88 | TRUE | 0 | 0 |
| 2025-11-21 | 165 | 0 | CALL | 0 | 0 | 50.37 | TRUE | 0 | 0 |
| 2025-11-21 | 170 | 0 | CALL | 0 | 0 | 47.46 | TRUE | 0 | 0 |
| 2025-11-21 | 175 | 0 | CALL | 0 | 0 | 47.37 | TRUE | 0 | 0 |
| 2025-11-21 | 180 | 0 | CALL | 0 | 0 | 48.61 | TRUE | 0 | 0 |
| 2025-11-21 | 185 | 0 | CALL | 0 | 0 | 48.05 | TRUE | 0 | 0 |
| 2025-11-21 | 190 | 0 | CALL | 0 | 0 | 46.93 | TRUE | 0 | 0 |
| 2025-11-21 | 195 | 13.2 | CALL | 0 | 1 | 46.02 | TRUE | 0 | 0 |
| 2025-11-21 | 200 | 13.8 | CALL | 0 | 1 | 45.06 | TRUE | 0 | 0 |
| 2025-11-21 | 210 | 11.42 | CALL | 2 | 26 | 45.88 | FALSE | 11.42 | 0 |
| 2025-11-21 | 220 | 6.7 | CALL | 0 | 2 | 43.52 | FALSE | 0 | 0 |
| 2025-11-21 | 230 | 0 | CALL | 0 | 0 | 42.39 | FALSE | 0 | 0 |
| 2025-11-21 | 240 | 0 | CALL | 0 | 0 | 41.1 | FALSE | 0 | 0 |
| 2025-11-21 | 250 | 0 | CALL | 0 | 0 | 40.39 | FALSE | 0 | 0 |
| 2025-11-21 | 260 | 0 | CALL | 0 | 0 | 39.23 | FALSE | 0 | 0 |
| 2025-11-21 | 270 | 0 | CALL | 0 | 0 | 39.42 | FALSE | 0 | 0 |
| 2025-11-21 | 280 | 0 | CALL | 0 | 0 | 46.3 | FALSE | 0 | 0 |
| 2025-11-21 | 290 | 0 | CALL | 0 | 0 | 50.44 | FALSE | 0 | 0 |
| 2025-11-21 | 140 | 0 | PUT | 0 | 0 | 58.32 | FALSE | 0 | 0 |
| 2025-11-21 | 145 | 0 | PUT | 0 | 0 | 51.61 | FALSE | 0 | 0 |
| 2025-11-21 | 150 | 0 | PUT | 0 | 0 | 50.98 | FALSE | 0 | 0 |
| 2025-11-21 | 155 | 2 | PUT | 0 | 1 | 51.26 | FALSE | 0 | 0 |
| 2025-11-21 | 160 | 2.6 | PUT | 0 | 2 | 50.69 | FALSE | 0 | 0 |
| 2025-11-21 | 165 | 0 | PUT | 0 | 0 | 49.93 | FALSE | 0 | 0 |
| 2025-11-21 | 170 | 2.65 | PUT | 1 | 3 | 50.19 | FALSE | 2.65 | 0 |
| 2025-11-21 | 175 | 5.8 | PUT | 0 | 50 | 48.71 | FALSE | 0 | 0 |
| 2025-11-21 | 180 | 5.46 | PUT | 0 | 54 | 47.7 | FALSE | 0 | 0 |
| 2025-11-21 | 185 | 10.5 | PUT | 0 | 1 | 47.32 | FALSE | 0 | 0 |
| 2025-11-21 | 190 | 0 | PUT | 0 | 0 | 46.33 | FALSE | 0 | 0 |
| 2025-11-21 | 195 | 0 | PUT | 0 | 0 | 45.89 | FALSE | 0 | 0 |
| 2025-11-21 | 200 | 0 | PUT | 0 | 0 | 45.85 | FALSE | 0 | 0 |
| 2025-11-21 | 210 | 0 | PUT | 0 | 0 | 43.74 | TRUE | 0 | 0 |
| 2025-11-21 | 220 | 0 | PUT | 0 | 0 | 42.17 | TRUE | 0 | 0 |
| 2025-11-21 | 230 | 0 | PUT | 0 | 0 | 44.31 | TRUE | 0 | 0 |
| 2025-11-21 | 240 | 0 | PUT | 0 | 0 | 42.22 | TRUE | 0 | 0 |
| 2025-11-21 | 250 | 0 | PUT | 0 | 0 | 38.23 | TRUE | 0 | 0 |
| 2025-11-21 | 260 | 0 | PUT | 0 | 0 | 43.8 | TRUE | 0 | 0 |
| 2025-11-21 | 270 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2025-11-21 | 280 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2025-11-21 | 290 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2025-12-19 | 60 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2025-12-19 | 65 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2025-12-19 | 70 | 0 | CALL | 0 | 0 | 86.63 | TRUE | 0 | 0 |
| 2025-12-19 | 75 | 0 | CALL | 0 | 1 | 0 | TRUE | 0 | 0 |
| 2025-12-19 | 80 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2025-12-19 | 85 | 0 | CALL | 0 | 0 | 90.83 | TRUE | 0 | 0 |
| 2025-12-19 | 90 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2025-12-19 | 95 | 0 | CALL | 0 | 0 | 80.78 | TRUE | 0 | 0 |
| 2025-12-19 | 100 | 0 | CALL | 0 | 0 | 70.01 | TRUE | 0 | 0 |
| 2025-12-19 | 105 | 89 | CALL | 0 | 1 | 63.42 | TRUE | 0 | 0 |
| 2025-12-19 | 110 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2025-12-19 | 115 | 0 | CALL | 0 | 0 | 56.21 | TRUE | 0 | 0 |
| 2025-12-19 | 120 | 0 | CALL | 0 | 0 | 60.57 | TRUE | 0 | 0 |
| 2025-12-19 | 125 | 79.9 | CALL | 0 | 38 | 57.75 | TRUE | 0 | 0 |
| 2025-12-19 | 130 | 0 | CALL | 0 | 1 | 50.63 | TRUE | 0 | 0 |
| 2025-12-19 | 135 | 0 | CALL | 0 | 1 | 45.91 | TRUE | 0 | 0 |
| 2025-12-19 | 140 | 0 | CALL | 0 | 3 | 50.3 | TRUE | 0 | 0 |
| 2025-12-19 | 145 | 45.54 | CALL | 0 | 2 | 48.31 | TRUE | 0 | 0 |
| 2025-12-19 | 150 | 50.4 | CALL | 0 | 3 | 50.49 | TRUE | 0 | 0 |
| 2025-12-19 | 155 | 0 | CALL | 0 | 0 | 46 | TRUE | 0 | 0 |
| 2025-12-19 | 160 | 43.23 | CALL | 0 | 67 | 48.47 | TRUE | 0 | 0 |
| 2025-12-19 | 165 | 43.79 | CALL | 0 | 1 | 47.81 | TRUE | 0 | 0 |
| 2025-12-19 | 170 | 42.2 | CALL | 0 | 271 | 47.18 | TRUE | 0 | 0 |
| 2025-12-19 | 175 | 31.9 | CALL | 0 | 5 | 48.25 | TRUE | 0 | 0 |
| 2025-12-19 | 180 | 34.23 | CALL | 0 | 86 | 46.97 | TRUE | 0 | 0 |
| 2025-12-19 | 185 | 31.1 | CALL | 0 | 29 | 47.76 | TRUE | 0 | 0 |
| 2025-12-19 | 190 | 21.05 | CALL | 0 | 5 | 47.46 | TRUE | 0 | 0 |
| 2025-12-19 | 195 | 21 | CALL | 0 | 63 | 48.24 | TRUE | 0 | 0 |
| 2025-12-19 | 200 | 17 | CALL | 0 | 210 | 47.5 | TRUE | 0 | 0 |
| 2025-12-19 | 210 | 9.6 | CALL | 0 | 163 | 46.43 | FALSE | 0 | 0 |
| 2025-12-19 | 220 | 10.83 | CALL | 5 | 48 | 44.17 | FALSE | 10.83 | 0 |
| 2025-12-19 | 230 | 7.43 | CALL | 5 | 261 | 42.72 | FALSE | 7.43 | 0 |
| 2025-12-19 | 240 | 6 | CALL | 0 | 5 | 42.17 | FALSE | 0 | 0 |
| 2025-12-19 | 250 | 4.3 | CALL | 0 | 8 | 41.24 | FALSE | 0 | 0 |
| 2025-12-19 | 260 | 3.2 | CALL | 0 | 10 | 39.82 | FALSE | 0 | 0 |
| 2025-12-19 | 270 | 2.15 | CALL | 0 | 8 | 39.01 | FALSE | 0 | 0 |
| 2025-12-19 | 280 | 1.45 | CALL | 0 | 6 | 38.26 | FALSE | 0 | 0 |
| 2025-12-19 | 290 | 0.95 | CALL | 0 | 4 | 37.53 | FALSE | 0 | 0 |
| 2025-12-19 | 60 | 0 | PUT | 0 | 0 | 132.78 | FALSE | 0 | 0 |
| 2025-12-19 | 65 | 0 | PUT | 0 | 1 | 124.59 | FALSE | 0 | 0 |
| 2025-12-19 | 70 | 0 | PUT | 0 | 0 | 117.04 | FALSE | 0 | 0 |
| 2025-12-19 | 75 | 0 | PUT | 0 | 0 | 110.03 | FALSE | 0 | 0 |
| 2025-12-19 | 80 | 0 | PUT | 0 | 20 | 103.5 | FALSE | 0 | 0 |
| 2025-12-19 | 85 | 0 | PUT | 0 | 1 | 97.37 | FALSE | 0 | 0 |
| 2025-12-19 | 90 | 0 | PUT | 0 | 21 | 91.59 | FALSE | 0 | 0 |
| 2025-12-19 | 95 | 0 | PUT | 0 | 1 | 86.14 | FALSE | 0 | 0 |
| 2025-12-19 | 100 | 0 | PUT | 0 | 1 | 80.96 | FALSE | 0 | 0 |
| 2025-12-19 | 105 | 2.1 | PUT | 0 | 3 | 76.03 | FALSE | 0 | 0 |
| 2025-12-19 | 110 | 2.65 | PUT | 0 | 4 | 71.32 | FALSE | 0 | 0 |
| 2025-12-19 | 115 | 0.6 | PUT | 0 | 0 | 66.81 | FALSE | 0 | 0 |
| 2025-12-19 | 120 | 0.85 | PUT | 0 | 2 | 62.48 | FALSE | 0 | 0 |
| 2025-12-19 | 125 | 1.05 | PUT | 0 | 0 | 53.67 | FALSE | 0 | 0 |
| 2025-12-19 | 130 | 0 | PUT | 0 | 1 | 51.15 | FALSE | 0 | 0 |
| 2025-12-19 | 135 | 1 | PUT | 0 | 0 | 49.5 | FALSE | 0 | 0 |
| 2025-12-19 | 140 | 9.23 | PUT | 0 | 76 | 48.98 | FALSE | 0 | 0 |
| 2025-12-19 | 145 | 0 | PUT | 0 | 1 | 49.38 | FALSE | 0 | 0 |
| 2025-12-19 | 150 | 0 | PUT | 0 | 0 | 48.7 | FALSE | 0 | 0 |
| 2025-12-19 | 155 | 0 | PUT | 0 | 0 | 48.78 | FALSE | 0 | 0 |
| 2025-12-19 | 160 | 0 | PUT | 0 | 0 | 48.56 | FALSE | 0 | 0 |
| 2025-12-19 | 165 | 0 | PUT | 0 | 0 | 48.58 | FALSE | 0 | 0 |
| 2025-12-19 | 170 | 7.3 | PUT | 0 | 315 | 48.44 | FALSE | 0 | 0 |
| 2025-12-19 | 175 | 0 | PUT | 0 | 0 | 48.34 | FALSE | 0 | 0 |
| 2025-12-19 | 180 | 11.73 | PUT | 0 | 1 | 48.22 | FALSE | 0 | 0 |
| 2025-12-19 | 185 | 27.5 | PUT | 0 | 166 | 48.04 | FALSE | 0 | 0 |
| 2025-12-19 | 190 | 15.2 | PUT | 0 | 5 | 46.9 | FALSE | 0 | 0 |
| 2025-12-19 | 195 | 17.15 | PUT | 0 | 1 | 47.49 | FALSE | 0 | 0 |
| 2025-12-19 | 200 | 12.9 | PUT | 2 | 20 | 47.11 | FALSE | 12.9 | 0 |
| 2025-12-19 | 210 | 0 | PUT | 0 | 1 | 46.15 | TRUE | 0 | 0 |
| 2025-12-19 | 220 | 51.9 | PUT | 0 | 3 | 45.2 | TRUE | 0 | 0 |
| 2025-12-19 | 230 | 0 | PUT | 0 | 0 | 43.94 | TRUE | 0 | 0 |
| 2025-12-19 | 240 | 0 | PUT | 0 | 1 | 42.61 | TRUE | 0 | 0 |
| 2025-12-19 | 250 | 0 | PUT | 0 | 0 | 40.84 | TRUE | 0 | 0 |
| 2025-12-19 | 260 | 77.4 | PUT | 0 | 0 | 41.64 | TRUE | 0 | 0 |
| 2025-12-19 | 270 | 0 | PUT | 0 | 0 | 42.48 | TRUE | 0 | 0 |
| 2025-12-19 | 280 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2025-12-19 | 290 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2026-01-16 | 75 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2026-01-16 | 80 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2026-01-16 | 85 | 0 | CALL | 0 | 0 | 80.18 | TRUE | 0 | 0 |
| 2026-01-16 | 90 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2026-01-16 | 95 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2026-01-16 | 100 | 0 | CALL | 0 | 0 | 67.42 | TRUE | 0 | 0 |
| 2026-01-16 | 105 | 0 | CALL | 0 | 0 | 48.88 | TRUE | 0 | 0 |
| 2026-01-16 | 110 | 0 | CALL | 0 | 0 | 30.52 | TRUE | 0 | 0 |
| 2026-01-16 | 115 | 0 | CALL | 0 | 0 | 58.22 | TRUE | 0 | 0 |
| 2026-01-16 | 120 | 0 | CALL | 0 | 0 | 46.18 | TRUE | 0 | 0 |
| 2026-01-16 | 125 | 0 | CALL | 0 | 0 | 53.67 | TRUE | 0 | 0 |
| 2026-01-16 | 130 | 0 | CALL | 0 | 0 | 51.82 | TRUE | 0 | 0 |
| 2026-01-16 | 135 | 45.5 | CALL | 0 | 1 | 47.57 | TRUE | 0 | 0 |
| 2026-01-16 | 140 | 0 | CALL | 0 | 0 | 48.41 | TRUE | 0 | 0 |
| 2026-01-16 | 145 | 0 | CALL | 0 | 0 | 48.88 | TRUE | 0 | 0 |
| 2026-01-16 | 150 | 37.5 | CALL | 0 | 0 | 46.69 | TRUE | 0 | 0 |
| 2026-01-16 | 155 | 0 | CALL | 0 | 0 | 46.49 | TRUE | 0 | 0 |
| 2026-01-16 | 160 | 43.47 | CALL | 0 | 6 | 46.56 | TRUE | 0 | 0 |
| 2026-01-16 | 165 | 39.75 | CALL | 0 | 17 | 47.14 | TRUE | 0 | 0 |
| 2026-01-16 | 170 | 36.8 | CALL | 0 | 211 | 47.66 | TRUE | 0 | 0 |
| 2026-01-16 | 175 | 25.7 | CALL | 0 | 6 | 45.94 | TRUE | 0 | 0 |
| 2026-01-16 | 180 | 31.3 | CALL | 0 | 7 | 45.66 | TRUE | 0 | 0 |
| 2026-01-16 | 185 | 28.75 | CALL | 0 | 216 | 45.69 | TRUE | 0 | 0 |
| 2026-01-16 | 190 | 21.7 | CALL | 0 | 7 | 45.18 | TRUE | 0 | 0 |
| 2026-01-16 | 195 | 25.48 | CALL | 1 | 10 | 45.87 | TRUE | 25.48 | 0 |
| 2026-01-16 | 200 | 19.8 | CALL | 0 | 46 | 44.46 | TRUE | 0 | 0 |
| 2026-01-16 | 210 | 18.2 | CALL | 0 | 13 | 43.51 | FALSE | 0 | 0 |
| 2026-01-16 | 220 | 14.1 | CALL | 0 | 1 | 42.61 | FALSE | 0 | 0 |
| 2026-01-16 | 230 | 8.95 | CALL | 0 | 429 | 41.32 | FALSE | 0 | 0 |
| 2026-01-16 | 240 | 5.46 | CALL | 0 | 1461 | 40.23 | FALSE | 0 | 0 |
| 2026-01-16 | 250 | 4.83 | CALL | 0 | 3 | 39.62 | FALSE | 0 | 0 |
| 2026-01-16 | 260 | 2.5 | CALL | 0 | 1 | 38.61 | FALSE | 0 | 0 |
| 2026-01-16 | 270 | 0 | CALL | 0 | 0 | 38.05 | FALSE | 0 | 0 |
| 2026-01-16 | 280 | 1.6 | CALL | 0 | 4 | 37.71 | FALSE | 0 | 0 |
| 2026-01-16 | 290 | 1.25 | CALL | 0 | 3 | 36.78 | FALSE | 0 | 0 |
| 2026-01-16 | 300 | 0 | CALL | 0 | 0 | 37.06 | FALSE | 0 | 0 |
| 2026-01-16 | 75 | 0 | PUT | 0 | 0 | 94.29 | FALSE | 0 | 0 |
| 2026-01-16 | 80 | 0 | PUT | 0 | 0 | 88.7 | FALSE | 0 | 0 |
| 2026-01-16 | 85 | 0 | PUT | 0 | 0 | 83.46 | FALSE | 0 | 0 |
| 2026-01-16 | 90 | 0 | PUT | 0 | 0 | 78.52 | FALSE | 0 | 0 |
| 2026-01-16 | 95 | 0 | PUT | 0 | 0 | 73.85 | FALSE | 0 | 0 |
| 2026-01-16 | 100 | 0 | PUT | 0 | 0 | 69.43 | FALSE | 0 | 0 |
| 2026-01-16 | 105 | 0 | PUT | 0 | 0 | 65.21 | FALSE | 0 | 0 |
| 2026-01-16 | 110 | 0.75 | PUT | 0 | 2 | 61.19 | FALSE | 0 | 0 |
| 2026-01-16 | 115 | 0 | PUT | 0 | 0 | 52.87 | FALSE | 0 | 0 |
| 2026-01-16 | 120 | 0 | PUT | 0 | 0 | 49.41 | FALSE | 0 | 0 |
| 2026-01-16 | 125 | 0 | PUT | 0 | 0 | 49.19 | FALSE | 0 | 0 |
| 2026-01-16 | 130 | 0 | PUT | 0 | 5 | 48.18 | FALSE | 0 | 0 |
| 2026-01-16 | 135 | 5.23 | PUT | 0 | 27 | 48.44 | FALSE | 0 | 0 |
| 2026-01-16 | 140 | 3.78 | PUT | 0 | 19 | 47.8 | FALSE | 0 | 0 |
| 2026-01-16 | 145 | 0 | PUT | 0 | 14 | 47.71 | FALSE | 0 | 0 |
| 2026-01-16 | 150 | 10.9 | PUT | 0 | 8 | 47.22 | FALSE | 0 | 0 |
| 2026-01-16 | 155 | 5.6 | PUT | 0 | 1 | 47.95 | FALSE | 0 | 0 |
| 2026-01-16 | 160 | 7.58 | PUT | 0 | 2 | 46.29 | FALSE | 0 | 0 |
| 2026-01-16 | 165 | 6.8 | PUT | 0 | 24 | 46.7 | FALSE | 0 | 0 |
| 2026-01-16 | 170 | 9.35 | PUT | 0 | 29 | 46.74 | FALSE | 0 | 0 |
| 2026-01-16 | 175 | 26.1 | PUT | 0 | 1 | 46.19 | FALSE | 0 | 0 |
| 2026-01-16 | 180 | 8.5 | PUT | 1 | 16 | 46.01 | FALSE | 8.5 | 0 |
| 2026-01-16 | 185 | 10 | PUT | 0 | 226 | 45.31 | FALSE | 0 | 0 |
| 2026-01-16 | 190 | 14.49 | PUT | 0 | 7 | 45.68 | FALSE | 0 | 0 |
| 2026-01-16 | 195 | 23.7 | PUT | 0 | 8 | 45.75 | FALSE | 0 | 0 |
| 2026-01-16 | 200 | 25.6 | PUT | 0 | 8 | 45.07 | FALSE | 0 | 0 |
| 2026-01-16 | 210 | 28.6 | PUT | 0 | 1 | 43.29 | TRUE | 0 | 0 |
| 2026-01-16 | 220 | 0 | PUT | 0 | 0 | 42.9 | TRUE | 0 | 0 |
| 2026-01-16 | 230 | 0 | PUT | 0 | 0 | 42.35 | TRUE | 0 | 0 |
| 2026-01-16 | 240 | 0 | PUT | 0 | 0 | 41.51 | TRUE | 0 | 0 |
| 2026-01-16 | 250 | 0 | PUT | 0 | 0 | 40.13 | TRUE | 0 | 0 |
| 2026-01-16 | 260 | 0 | PUT | 0 | 0 | 37.98 | TRUE | 0 | 0 |
| 2026-01-16 | 270 | 0 | PUT | 0 | 0 | 38.62 | TRUE | 0 | 0 |
| 2026-01-16 | 280 | 0 | PUT | 0 | 0 | 39.81 | TRUE | 0 | 0 |
| 2026-01-16 | 290 | 0 | PUT | 0 | 0 | 42.08 | TRUE | 0 | 0 |
| 2026-01-16 | 300 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2026-04-17 | 100 | 0 | CALL | 0 | 0 | 51.97 | TRUE | 0 | 0 |
| 2026-04-17 | 105 | 0 | CALL | 0 | 0 | 52.79 | TRUE | 0 | 0 |
| 2026-04-17 | 110 | 0 | CALL | 0 | 0 | 51.7 | TRUE | 0 | 0 |
| 2026-04-17 | 115 | 0 | CALL | 0 | 0 | 50.32 | TRUE | 0 | 0 |
| 2026-04-17 | 120 | 0 | CALL | 0 | 0 | 48.76 | TRUE | 0 | 0 |
| 2026-04-17 | 125 | 0 | CALL | 0 | 0 | 49.57 | TRUE | 0 | 0 |
| 2026-04-17 | 130 | 0 | CALL | 0 | 0 | 49.62 | TRUE | 0 | 0 |
| 2026-04-17 | 135 | 0 | CALL | 0 | 0 | 48.28 | TRUE | 0 | 0 |
| 2026-04-17 | 140 | 0 | CALL | 0 | 0 | 48.36 | TRUE | 0 | 0 |
| 2026-04-17 | 145 | 0 | CALL | 0 | 0 | 47.99 | TRUE | 0 | 0 |
| 2026-04-17 | 150 | 0 | CALL | 0 | 0 | 49.14 | TRUE | 0 | 0 |
| 2026-04-17 | 155 | 0 | CALL | 0 | 0 | 47.72 | TRUE | 0 | 0 |
| 2026-04-17 | 160 | 0 | CALL | 0 | 0 | 47.46 | TRUE | 0 | 0 |
| 2026-04-17 | 165 | 0 | CALL | 0 | 0 | 47.36 | TRUE | 0 | 0 |
| 2026-04-17 | 170 | 0 | CALL | 0 | 0 | 46.71 | TRUE | 0 | 0 |
| 2026-04-17 | 175 | 39.62 | CALL | 0 | 17 | 46.24 | TRUE | 0 | 0 |
| 2026-04-17 | 180 | 0 | CALL | 0 | 0 | 45.9 | TRUE | 0 | 0 |
| 2026-04-17 | 185 | 0 | CALL | 0 | 0 | 45.68 | TRUE | 0 | 0 |
| 2026-04-17 | 190 | 0 | CALL | 0 | 0 | 45.2 | TRUE | 0 | 0 |
| 2026-04-17 | 195 | 0 | CALL | 0 | 0 | 45.18 | TRUE | 0 | 0 |
| 2026-04-17 | 200 | 27.7 | CALL | 0 | 2 | 44.38 | TRUE | 0 | 0 |
| 2026-04-17 | 210 | 27.9 | CALL | 0 | 1 | 43.46 | FALSE | 0 | 0 |
| 2026-04-17 | 220 | 0 | CALL | 0 | 0 | 42.95 | FALSE | 0 | 0 |
| 2026-04-17 | 230 | 17.75 | CALL | 0 | 1 | 42.55 | FALSE | 0 | 0 |
| 2026-04-17 | 240 | 0 | CALL | 0 | 0 | 41.62 | FALSE | 0 | 0 |
| 2026-04-17 | 250 | 0 | CALL | 0 | 0 | 41.28 | FALSE | 0 | 0 |
| 2026-04-17 | 260 | 0 | CALL | 0 | 0 | 40.3 | FALSE | 0 | 0 |
| 2026-04-17 | 270 | 0 | CALL | 0 | 0 | 39.73 | FALSE | 0 | 0 |
| 2026-04-17 | 280 | 0 | CALL | 0 | 0 | 38.54 | FALSE | 0 | 0 |
| 2026-04-17 | 290 | 2.6 | CALL | 0 | 4 | 38.33 | FALSE | 0 | 0 |
| 2026-04-17 | 300 | 1.85 | CALL | 0 | 3 | 37.38 | FALSE | 0 | 0 |
| 2026-04-17 | 100 | 0 | PUT | 0 | 0 | 49.44 | FALSE | 0 | 0 |
| 2026-04-17 | 105 | 0 | PUT | 0 | 0 | 49.64 | FALSE | 0 | 0 |
| 2026-04-17 | 110 | 2.15 | PUT | 0 | 1 | 49.08 | FALSE | 0 | 0 |
| 2026-04-17 | 115 | 2.7 | PUT | 0 | 1 | 49.01 | FALSE | 0 | 0 |
| 2026-04-17 | 120 | 0 | PUT | 0 | 0 | 48.74 | FALSE | 0 | 0 |
| 2026-04-17 | 125 | 0 | PUT | 0 | 0 | 48.61 | FALSE | 0 | 0 |
| 2026-04-17 | 130 | 0 | PUT | 0 | 0 | 49.04 | FALSE | 0 | 0 |
| 2026-04-17 | 135 | 0 | PUT | 0 | 0 | 48.85 | FALSE | 0 | 0 |
| 2026-04-17 | 140 | 0 | PUT | 0 | 0 | 48.06 | FALSE | 0 | 0 |
| 2026-04-17 | 145 | 0 | PUT | 0 | 0 | 47.69 | FALSE | 0 | 0 |
| 2026-04-17 | 150 | 0 | PUT | 0 | 0 | 47.6 | FALSE | 0 | 0 |
| 2026-04-17 | 155 | 0 | PUT | 0 | 0 | 47.12 | FALSE | 0 | 0 |
| 2026-04-17 | 160 | 0 | PUT | 0 | 0 | 47 | FALSE | 0 | 0 |
| 2026-04-17 | 165 | 0 | PUT | 0 | 0 | 46.53 | FALSE | 0 | 0 |
| 2026-04-17 | 170 | 0 | PUT | 0 | 0 | 46.34 | FALSE | 0 | 0 |
| 2026-04-17 | 175 | 0 | PUT | 0 | 0 | 46.05 | FALSE | 0 | 0 |
| 2026-04-17 | 180 | 17.5 | PUT | 0 | 1 | 46.48 | FALSE | 0 | 0 |
| 2026-04-17 | 185 | 18.04 | PUT | 0 | 0 | 45.6 | FALSE | 0 | 0 |
| 2026-04-17 | 190 | 21.6 | PUT | 0 | 7 | 45.05 | FALSE | 0 | 0 |
| 2026-04-17 | 195 | 0 | PUT | 0 | 0 | 44.79 | FALSE | 0 | 0 |
| 2026-04-17 | 200 | 0 | PUT | 0 | 0 | 44.45 | FALSE | 0 | 0 |
| 2026-04-17 | 210 | 0 | PUT | 0 | 0 | 43.69 | TRUE | 0 | 0 |
| 2026-04-17 | 220 | 0 | PUT | 0 | 0 | 42.96 | TRUE | 0 | 0 |
| 2026-04-17 | 230 | 0 | PUT | 0 | 0 | 42.29 | TRUE | 0 | 0 |
| 2026-04-17 | 240 | 0 | PUT | 0 | 0 | 41.17 | TRUE | 0 | 0 |
| 2026-04-17 | 250 | 0 | PUT | 0 | 0 | 40.93 | TRUE | 0 | 0 |
| 2026-04-17 | 260 | 0 | PUT | 0 | 0 | 40.55 | TRUE | 0 | 0 |
| 2026-04-17 | 270 | 0 | PUT | 0 | 0 | 39.38 | TRUE | 0 | 0 |
| 2026-04-17 | 280 | 0 | PUT | 0 | 0 | 38.5 | TRUE | 0 | 0 |
| 2026-04-17 | 290 | 0 | PUT | 0 | 0 | 39.27 | TRUE | 0 | 0 |
| 2026-04-17 | 300 | 0 | PUT | 0 | 0 | 39.06 | TRUE | 0 | 0 |
| 2026-06-18 | 80 | 0 | CALL | 0 | 0 | 54 | TRUE | 0 | 0 |
| 2026-06-18 | 85 | 0 | CALL | 0 | 0 | 54.07 | TRUE | 0 | 0 |
| 2026-06-18 | 90 | 0 | CALL | 0 | 0 | 53.41 | TRUE | 0 | 0 |
| 2026-06-18 | 95 | 0 | CALL | 0 | 0 | 53.42 | TRUE | 0 | 0 |
| 2026-06-18 | 100 | 0 | CALL | 0 | 0 | 52.83 | TRUE | 0 | 0 |
| 2026-06-18 | 105 | 0 | CALL | 0 | 0 | 51.87 | TRUE | 0 | 0 |
| 2026-06-18 | 110 | 0 | CALL | 0 | 0 | 51.93 | TRUE | 0 | 0 |
| 2026-06-18 | 115 | 0 | CALL | 0 | 0 | 50.96 | TRUE | 0 | 0 |
| 2026-06-18 | 120 | 0 | CALL | 0 | 0 | 50.25 | TRUE | 0 | 0 |
| 2026-06-18 | 125 | 0 | CALL | 0 | 0 | 50.11 | TRUE | 0 | 0 |
| 2026-06-18 | 130 | 0 | CALL | 0 | 0 | 49.61 | TRUE | 0 | 0 |
| 2026-06-18 | 135 | 0 | CALL | 0 | 0 | 48.83 | TRUE | 0 | 0 |
| 2026-06-18 | 140 | 0 | CALL | 0 | 10 | 47.84 | TRUE | 0 | 0 |
| 2026-06-18 | 145 | 0 | CALL | 0 | 0 | 48.6 | TRUE | 0 | 0 |
| 2026-06-18 | 150 | 0 | CALL | 0 | 0 | 48.17 | TRUE | 0 | 0 |
| 2026-06-18 | 155 | 51.5 | CALL | 0 | 2 | 47.72 | TRUE | 0 | 0 |
| 2026-06-18 | 160 | 49 | CALL | 0 | 2 | 47.48 | TRUE | 0 | 0 |
| 2026-06-18 | 165 | 36.9 | CALL | 0 | 2 | 47.61 | TRUE | 0 | 0 |
| 2026-06-18 | 170 | 37 | CALL | 0 | 10 | 46.5 | TRUE | 0 | 0 |
| 2026-06-18 | 175 | 42.7 | CALL | 0 | 1 | 46.35 | TRUE | 0 | 0 |
| 2026-06-18 | 180 | 44 | CALL | 0 | 7 | 45.8 | TRUE | 0 | 0 |
| 2026-06-18 | 185 | 31.8 | CALL | 0 | 1 | 45.56 | TRUE | 0 | 0 |
| 2026-06-18 | 190 | 35.5 | CALL | 0 | 11 | 45.12 | TRUE | 0 | 0 |
| 2026-06-18 | 195 | 35.8 | CALL | 0 | 3 | 44.81 | TRUE | 0 | 0 |
| 2026-06-18 | 200 | 34.64 | CALL | 0 | 6 | 44.31 | TRUE | 0 | 0 |
| 2026-06-18 | 210 | 30 | CALL | 0 | 13 | 43.54 | FALSE | 0 | 0 |
| 2026-06-18 | 220 | 24.51 | CALL | 0 | 4 | 43.24 | FALSE | 0 | 0 |
| 2026-06-18 | 230 | 18.5 | CALL | 0 | 4 | 42.49 | FALSE | 0 | 0 |
| 2026-06-18 | 240 | 0 | CALL | 0 | 0 | 41.68 | FALSE | 0 | 0 |
| 2026-06-18 | 250 | 13.5 | CALL | 0 | 1 | 40.76 | FALSE | 0 | 0 |
| 2026-06-18 | 260 | 0 | CALL | 0 | 0 | 40.31 | FALSE | 0 | 0 |
| 2026-06-18 | 270 | 0 | CALL | 0 | 0 | 39.42 | FALSE | 0 | 0 |
| 2026-06-18 | 280 | 0 | CALL | 0 | 0 | 39 | FALSE | 0 | 0 |
| 2026-06-18 | 290 | 0 | CALL | 0 | 0 | 38.83 | FALSE | 0 | 0 |
| 2026-06-18 | 300 | 0 | CALL | 0 | 0 | 38.36 | FALSE | 0 | 0 |
| 2026-06-18 | 80 | 0 | PUT | 0 | 0 | 53 | FALSE | 0 | 0 |
| 2026-06-18 | 85 | 0 | PUT | 0 | 0 | 49.89 | FALSE | 0 | 0 |
| 2026-06-18 | 90 | 0 | PUT | 0 | 0 | 49.9 | FALSE | 0 | 0 |
| 2026-06-18 | 95 | 0 | PUT | 0 | 0 | 49.89 | FALSE | 0 | 0 |
| 2026-06-18 | 100 | 0 | PUT | 0 | 0 | 49.79 | FALSE | 0 | 0 |
| 2026-06-18 | 105 | 0 | PUT | 0 | 0 | 49.56 | FALSE | 0 | 0 |
| 2026-06-18 | 110 | 0 | PUT | 0 | 0 | 49.56 | FALSE | 0 | 0 |
| 2026-06-18 | 115 | 0 | PUT | 0 | 0 | 49.34 | FALSE | 0 | 0 |
| 2026-06-18 | 120 | 0 | PUT | 0 | 0 | 48.97 | FALSE | 0 | 0 |
| 2026-06-18 | 125 | 4 | PUT | 0 | 4 | 48.89 | FALSE | 0 | 0 |
| 2026-06-18 | 130 | 9.08 | PUT | 0 | 0 | 48.24 | FALSE | 0 | 0 |
| 2026-06-18 | 135 | 0 | PUT | 0 | 0 | 48.01 | FALSE | 0 | 0 |
| 2026-06-18 | 140 | 0 | PUT | 0 | 0 | 48.06 | FALSE | 0 | 0 |
| 2026-06-18 | 145 | 0 | PUT | 0 | 0 | 47.48 | FALSE | 0 | 0 |
| 2026-06-18 | 150 | 16.25 | PUT | 0 | 2 | 47.43 | FALSE | 0 | 0 |
| 2026-06-18 | 155 | 22.5 | PUT | 0 | 1 | 47.07 | FALSE | 0 | 0 |
| 2026-06-18 | 160 | 16.2 | PUT | 0 | 2 | 46.89 | FALSE | 0 | 0 |
| 2026-06-18 | 165 | 25.21 | PUT | 0 | 2 | 46.46 | FALSE | 0 | 0 |
| 2026-06-18 | 170 | 25.05 | PUT | 0 | 2 | 46.57 | FALSE | 0 | 0 |
| 2026-06-18 | 175 | 26.3 | PUT | 0 | 44 | 45.87 | FALSE | 0 | 0 |
| 2026-06-18 | 180 | 33.3 | PUT | 0 | 9 | 45.5 | FALSE | 0 | 0 |
| 2026-06-18 | 185 | 35.6 | PUT | 0 | 8 | 45.1 | FALSE | 0 | 0 |
| 2026-06-18 | 190 | 0 | PUT | 0 | 0 | 45.13 | FALSE | 0 | 0 |
| 2026-06-18 | 195 | 30.4 | PUT | 0 | 1 | 44.64 | FALSE | 0 | 0 |
| 2026-06-18 | 200 | 44.5 | PUT | 0 | 2 | 44.42 | FALSE | 0 | 0 |
| 2026-06-18 | 210 | 38.5 | PUT | 0 | 1 | 43.54 | TRUE | 0 | 0 |
| 2026-06-18 | 220 | 0 | PUT | 0 | 0 | 42.52 | TRUE | 0 | 0 |
| 2026-06-18 | 230 | 0 | PUT | 0 | 0 | 42.4 | TRUE | 0 | 0 |
| 2026-06-18 | 240 | 0 | PUT | 0 | 0 | 41.86 | TRUE | 0 | 0 |
| 2026-06-18 | 250 | 0 | PUT | 0 | 0 | 40.76 | TRUE | 0 | 0 |
| 2026-06-18 | 260 | 90.48 | PUT | 0 | 269 | 40.36 | TRUE | 0 | 0 |
| 2026-06-18 | 270 | 0 | PUT | 0 | 0 | 39.42 | TRUE | 0 | 0 |
| 2026-06-18 | 280 | 0 | PUT | 0 | 0 | 39.45 | TRUE | 0 | 0 |
| 2026-06-18 | 290 | 0 | PUT | 0 | 0 | 38.18 | TRUE | 0 | 0 |
| 2026-06-18 | 300 | 0 | PUT | 0 | 0 | 37.3 | TRUE | 0 | 0 |
Latest ASND Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 7:59 PM EST | 100 | $79.93 |
| Jun 13, 2022 7:59 PM EST | 4 | $79.91 |
| Jun 13, 2022 7:59 PM EST | 118 | $79.93 |
| Jun 13, 2022 7:59 PM EST | 9 | $79.97 |
| Jun 13, 2022 7:59 PM EST | 17 | $79.97 |
Ascendis Pharma A/S (ASND) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-07-01 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1612042/000119312520185199/0001193125-20-185199-index.htm |
| 2019-06-10 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1612042/000008025519002847/0000080255-19-002847-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1612042/000008025520001284/0000080255-20-001284-index.htm |
| 2020-02-07 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1612042/000031506620000822/0000315066-20-000822-index.htm |
| 2019-03-12 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1612042/000094787119000203/0000947871-19-000203-index.htm |
| 2019-08-14 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1612042/000094787119000594/0000947871-19-000594-index.htm |
| 2020-03-05 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1612042/000094787120000185/0000947871-20-000185-index.htm |
| 2020-05-08 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1612042/000094787120000446/0000947871-20-000446-index.htm |
| 2020-05-22 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1612042/000094787120000511/0000947871-20-000511-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1612042/000110465920021751/0001104659-20-021751-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1612042/000110465920021912/0001104659-20-021912-index.htm |
| 2020-09-10 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1612042/000110465920103962/0001104659-20-103962-index.htm |
| 2019-02-15 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1612042/000119312519042416/0001193125-19-042416-index.htm |
| 2019-03-01 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1612042/000119312519059442/0001193125-19-059442-index.htm |
| 2019-03-04 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1612042/000119312519061604/0001193125-19-061604-index.htm |
| 2019-03-04 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1612042/000119312519062499/0001193125-19-062499-index.htm |
| 2019-03-06 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1612042/000119312519065750/0001193125-19-065750-index.htm |
| 2019-03-08 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1612042/000119312519069120/0001193125-19-069120-index.htm |
| 2019-03-14 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1612042/000119312519074983/0001193125-19-074983-index.htm |
| 2019-04-03 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1612042/000119312519096618/0001193125-19-096618-index.htm |
| 2019-04-03 | 20-F | Annual and transition report of foreign private issuers [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1612042/000119312519096759/0001193125-19-096759-index.htm |
| 2019-04-12 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1612042/000119312519105316/0001193125-19-105316-index.htm |
| 2019-04-19 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1612042/000119312519112380/0001193125-19-112380-index.htm |
| 2019-05-01 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1612042/000119312519133019/0001193125-19-133019-index.htm |
| 2019-05-16 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1612042/000119312519149447/0001193125-19-149447-index.htm |
| 2019-05-30 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1612042/000119312519161327/0001193125-19-161327-index.htm |
| 2019-05-30 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1612042/000119312519161365/0001193125-19-161365-index.htm |
| 2019-06-14 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1612042/000119312519173846/0001193125-19-173846-index.htm |
| 2019-06-18 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1612042/000119312519175289/0001193125-19-175289-index.htm |
| 2019-06-26 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1612042/000119312519181943/0001193125-19-181943-index.htm |
| 2019-07-01 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1612042/000119312519187411/0001193125-19-187411-index.htm |
| 2019-07-10 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1612042/000119312519191873/0001193125-19-191873-index.htm |
| 2019-07-18 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1612042/000119312519196527/0001193125-19-196527-index.htm |
| 2019-08-14 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1612042/000119312519221217/0001193125-19-221217-index.htm |
| 2019-08-28 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1612042/000119312519232458/0001193125-19-232458-index.htm |
| 2019-09-13 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1612042/000119312519244911/0001193125-19-244911-index.htm |
| 2019-09-26 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1612042/000119312519255970/0001193125-19-255970-index.htm |
| 2019-10-08 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1612042/000119312519263919/0001193125-19-263919-index.htm |
| 2019-10-10 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1612042/000119312519265843/0001193125-19-265843-index.htm |
| 2019-11-14 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1612042/000119312519292336/0001193125-19-292336-index.htm |
| 2019-11-15 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1612042/000119312519293431/0001193125-19-293431-index.htm |
| 2019-11-18 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1612042/000119312519294735/0001193125-19-294735-index.htm |
| 2019-12-12 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1612042/000119312519312728/0001193125-19-312728-index.htm |
| 2020-01-06 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1612042/000119312520002169/0001193125-20-002169-index.htm |
| 2020-01-13 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1612042/000119312520005786/0001193125-20-005786-index.htm |
| 2020-01-15 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1612042/000119312520008093/0001193125-20-008093-index.htm |
| 2020-02-12 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1612042/000119312520033240/0001193125-20-033240-index.htm |
| 2020-03-12 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1612042/000119312520071551/0001193125-20-071551-index.htm |
| 2020-03-31 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1612042/000119312520092940/0001193125-20-092940-index.htm |
| 2020-04-01 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1612042/000119312520094591/0001193125-20-094591-index.htm |
| 2020-04-03 | 20-F | Annual and transition report of foreign private issuers [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1612042/000119312520096870/0001193125-20-096870-index.htm |
| 2020-04-15 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1612042/000119312520108208/0001193125-20-108208-index.htm |
| 2020-04-20 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1612042/000119312520111593/0001193125-20-111593-index.htm |
| 2020-04-20 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1612042/000119312520112279/0001193125-20-112279-index.htm |
| 2020-04-30 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1612042/000119312520126717/0001193125-20-126717-index.htm |
| 2020-05-05 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1612042/000119312520133706/0001193125-20-133706-index.htm |
| 2020-05-15 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1612042/000119312520142982/0001193125-20-142982-index.htm |
| 2020-05-19 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1612042/000119312520146167/0001193125-20-146167-index.htm |
| 2020-06-01 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1612042/000119312520157336/0001193125-20-157336-index.htm |
| 2020-06-12 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1612042/000119312520167815/0001193125-20-167815-index.htm |
| 2020-06-26 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1612042/000119312520180048/0001193125-20-180048-index.htm |
| 2020-07-01 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1612042/000119312520185199/0001193125-20-185199-index.htm |
| 2020-07-06 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1612042/000119312520187456/0001193125-20-187456-index.htm |
| 2020-07-06 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1612042/000119312520187810/0001193125-20-187810-index.htm |
| 2020-07-09 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1612042/000119312520190428/0001193125-20-190428-index.htm |
| 2020-07-10 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1612042/000119312520191149/0001193125-20-191149-index.htm |
| 2020-07-17 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1612042/000119312520194325/0001193125-20-194325-index.htm |
| 2020-08-13 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1612042/000119312520219118/0001193125-20-219118-index.htm |
| 2020-08-27 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1612042/000119312520233148/0001193125-20-233148-index.htm |
| 2020-09-08 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1612042/000119312520241091/0001193125-20-241091-index.htm |
| 2020-09-10 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1612042/000119312520243078/0001193125-20-243078-index.htm |
| 2020-09-23 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1612042/000119312520252366/0001193125-20-252366-index.htm |
| 2020-09-29 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1612042/000119312520257235/0001193125-20-257235-index.htm |
| 2020-09-29 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1612042/000119312520257292/0001193125-20-257292-index.htm |
| 2020-10-05 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1612042/000119312520263856/0001193125-20-263856-index.htm |
| 2020-10-08 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1612042/000119312520265872/0001193125-20-265872-index.htm |
| 2020-10-16 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1612042/000119312520270385/0001193125-20-270385-index.htm |
| 2020-10-23 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1612042/000119312520275018/0001193125-20-275018-index.htm |
| 2019-10-23 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1612042/000121390019020915/0001213900-19-020915-index.htm |
| 2019-02-22 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1612042/999999999719000498/9999999997-19-000498-index.htm |
| 2020-07-15 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1612042/999999999720004106/9999999997-20-004106-index.htm |